Viyash Scientific Ltd (VIYASH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 213056,
    "name": "Viyash Scientifi",
    "stock_name": "Viyash Scientifi",
    "full_name": "Viyash Scientific Ltd",
    "name_url": "stocks-analysis/viyash-scientifi",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "273.80",
    "chg": -3.3,
    "chgp": "-1.19%",
    "dir": -1,
    "prev_price": "277.10",
    "mcapval": "12,073.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 512529,
    "symbol": "VIYASH",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE807F01027",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "20.79 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://marketsmojo.motilaloswal.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/viyash-scientifi-213056-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Viyash Scientific Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-viyash-scientific-ltd-latest-results-good-or-bad-4001454",
        "imagepath": "",
        "date": "2026-05-20 19:18:59",
        "description": "Viyash Scientific Ltd's latest financial results for Q4 FY26 reveal significant operational advancements, showcasing a remarkable turnaround from previous loss-making periods. The company reported net sales of ₹919.96 crores, reflecting a year-on-year growth of 129.02%, driven by strong demand in both Active Pharmaceutical Ingredients (APIs) and finished dosage formulations within the animal health segment. This performance marks an all-time high for the company, indicating robust market traction.\n\nNet profit for the quarter reached ₹52.11 crores, a substantial increase of 459.12% year-on-year. This surge in profitability is complemented by an operating margin of 20.03%, which has been sustained above 20% for three consecutive quarters—an improvement from the single-digit margins observed in early FY25. The company's operational efficiencies and a favorable product mix have contributed to this margin expans..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Viyash Scientific Ltd to 52-Week High of Rs 269",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-hits-new-52-week-high-at-rs269-4000918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ViyashScientifi_priceRelatedfactors_4000918.png",
        "date": "2026-05-20 10:35:12",
        "description": "Surging to a new 52-week high of Rs 269 on 20 May 2026, Viyash Scientific Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex. This milestone caps a three-day rally that has delivered a 15.79% return, underscoring the stock’s robust technical underpinnings."
      },
      {
        "title": "Viyash Scientific Ltd Surges on Exceptional Volume Amid Strong Accumulation Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-surges-on-exceptional-volume-amid-strong-accumulation-signals-4000619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ViyashScientifi_most_active_equities_by_volume_4000619.png",
        "date": "2026-05-20 10:00:07",
        "description": "Viyash Scientific Ltd (VIYASH) witnessed a remarkable surge in trading volume and price on 20 May 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector and broader market indices, signalling renewed investor interest and accumulation after a recent upgrade in its mojo rating."
      },
      {
        "title": "Viyash Scientific Ltd Surges on High-Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-surges-on-high-value-trading-and-institutional-interest-4000617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ViyashScientifi_most_active_equities_by_value_4000617.png",
        "date": "2026-05-20 10:00:07",
        "description": "Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 20 May 2026, driven by robust institutional interest and significant value turnover. The stock outperformed its sector and broader market indices, reflecting growing investor confidence amid a positive momentum shift."
      },
      {
        "title": "Viyash Scientific Ltd Surges 13.37% to Day's High of Rs 255.15 — Outperforms Sector by 10.37 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-hits-intraday-high-with-1337-surge-on-20-may-2026-4000537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ViyashScientifi_priceRelatedfactors_4000537.png",
        "date": "2026-05-20 09:45:57",
        "description": "The Sensex declined 0.5% on 20 May 2026, yet Viyash Scientific Ltd surged 13.37%, outperforming its Pharmaceuticals &amp; Biotechnology sector by over 10 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which has been on a three-day winning streak, raising the question: is this a breakout or a continuation of existing momentum?"
      },
      {
        "title": "When is the next results date for Viyash Scientific Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-viyash-scientific-ltd-3990087",
        "imagepath": "",
        "date": "2026-05-13 23:16:31",
        "description": "The next results date for Viyash Scientific Ltd is scheduled for 19 May 2026...."
      },
      {
        "title": "Viyash Scientific Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/viyash-scientific-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3988451",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ViyashScientifi_technicaldot_3988451.png",
        "date": "2026-05-13 08:00:53",
        "description": "Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 4.62% decline in its share price to ₹214.90, the stock's technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the evolving technical landscape and what it means for investors navigating this stock amid broader market trends."
      }
    ],
    "total": 15,
    "sid": "213056",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/viyash-scientific-213056"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Aug-2026",
      "details": "Intimation of Q1 FY27 Earnings Conference Call / Discussion on Financial Results for Quarter Ended June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Quarterly Results For Q1 FY 2026-27",
      "datetime": "03-Aug-2026",
      "details": "Viyash Scientific Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Quarterly Results for Q1 FY 2026-27",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "01-Aug-2026",
      "details": "ESOP Allotment",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(11 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Viyash Scientific Ltd has declared <strong>25%</strong> dividend, ex-date: 08 Sep 21",
          "dt": "2021-09-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Viyash Scientific Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 Feb 16",
          "dt": "2016-02-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Are Viyash Scientific Ltd latest results good or bad?

2026-05-20 19:18:59

Viyash Scientific Ltd's latest financial results for Q4 FY26 reveal significant operational advancements, showcasing a remarkable turnaround from previous loss-making periods. The company reported net sales of ₹919.96 crores, reflecting a year-on-year growth of 129.02%, driven by strong demand in both Active Pharmaceutical Ingredients (APIs) and finished dosage formulations within the animal health segment. This performance marks an all-time high for the company, indicating robust market traction. Net profit for the quarter reached ₹52.11 crores, a substantial increase of 459.12% year-on-year. This surge in profitability is complemented by an operating margin of 20.03%, which has been sustained above 20% for three consecutive quarters—an improvement from the single-digit margins observed in early FY25. The company's operational efficiencies and a favorable product mix have contributed to this margin expans...

Broad-Based Technical Strength Lifts Viyash Scientific Ltd to 52-Week High of Rs 269

2026-05-20 10:35:12

Surging to a new 52-week high of Rs 269 on 20 May 2026, Viyash Scientific Ltd has demonstrated remarkable price momentum, outperforming its sector and the broader market despite a subdued Sensex. This milestone caps a three-day rally that has delivered a 15.79% return, underscoring the stock’s robust technical underpinnings.

Viyash Scientific Ltd Surges on Exceptional Volume Amid Strong Accumulation Signals

2026-05-20 10:00:07

Viyash Scientific Ltd (VIYASH) witnessed a remarkable surge in trading volume and price on 20 May 2026, emerging as one of the most actively traded stocks in the Pharmaceuticals & Biotechnology sector. The stock outperformed its sector and broader market indices, signalling renewed investor interest and accumulation after a recent upgrade in its mojo rating.

Viyash Scientific Ltd Surges on High-Value Trading and Institutional Interest

2026-05-20 10:00:07

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 20 May 2026, driven by robust institutional interest and significant value turnover. The stock outperformed its sector and broader market indices, reflecting growing investor confidence amid a positive momentum shift.

Viyash Scientific Ltd Surges 13.37% to Day's High of Rs 255.15 — Outperforms Sector by 10.37 Percentage Points

2026-05-20 09:45:57

The Sensex declined 0.5% on 20 May 2026, yet Viyash Scientific Ltd surged 13.37%, outperforming its Pharmaceuticals & Biotechnology sector by over 10 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, which has been on a three-day winning streak, raising the question: is this a breakout or a continuation of existing momentum?

When is the next results date for Viyash Scientific Ltd?

2026-05-13 23:16:31

The next results date for Viyash Scientific Ltd is scheduled for 19 May 2026....

Viyash Scientific Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-13 08:00:53

Viyash Scientific Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent 4.62% decline in its share price to ₹214.90, the stock's technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the evolving technical landscape and what it means for investors navigating this stock amid broader market trends.

View All News